Navigation Links
Study IDs Protein That Inhibits HIV From Growing In Cell Cultures

ly destroys. HIV attaches to this T-cell by first landing on a receptor called CD4. Once it reacts with the receptor, HIV can enter the cell, multiply and destroy the T-cell, thereby causing immune deficiency.

"People with GBV-C have a slower rate of destruction of these T-cells," said Stapleton, who also is director of the Division of Infectious Diseases at the Iowa City VA and UI.

The current study shows that the newly identified protein, NS5A, inhibits HIV in part by decreasing the number of CD4 receptors available to HIV. With fewer places for HIV to "dock," less HIV enters the cells to inflict destruction.

However, Xiang cautioned, this is only part of the story, and the researchers must continue work to understand how the NS5A protein exerts its total effect.

"Before NS5A can be used for any kind of therapy, we need to further map it," Xiang said. "We need to zero in to see what region has the critical effect on HIV inhibition."

Once that is accomplished, the team will seek to develop small molecular drugs that mimic the inhibiting action.

Stapleton noted that GBV-C is not toxic to T-cells and is not associated with any human disease. As a result, the U.S. Food and Drug Administration does not require that blood donations be screened for this common virus.

Up to 3 percent of healthy blood donors in the United States have active GBV-C infection. An additional 12 percent have antibodies indicating past exposure at the time of donation. Because the GBV-virus is transmitted through bodily fluids, as is HIV, many HIV-positive individuals have evidence of past or present infection with GBV-C.

Stapleton and Xiang first began studying the GBV-C and HIV connection because they were skeptical of earlier studies published in the mid-1990s.

"It was a strange story," Stapleton said. "Who would have thought a virus floating around in a lot of people does not make them
'"/>




Page: 1 2 3

Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer

Post Your Comments:
(Date:11/7/2009)...ted for Life Action endorses a key vote today on t...r-Dahlkemper-Lipinski-Smith Amendment, an Amendmen...tion in health care reform. ,, Americans United fo...est said, "Americans United for Life Action strong...kemper-Lipinski-Smith Amendment to prohibit aborti...
(Date:11/7/2009)...youth will rebel, expert says , , SATURDAY... to behave badly if their parents expect them to, ... they are simply being realistic might actually co...uchanan, a psychology professor at Wake Forest Uni...ersity news release. "Negative expectations on the...
(Date:11/7/2009)...23-25th marked the 12th annual tournament bringing...tle against pediatric cancer. Stephen Updegraff, ...for many years. , St. Pet...end of October 23-25 marked the 12th annual tourn...ghting the battle against pediatric cancer– ...
(Date:11/7/2009)...lsquo;sweatox’ or ‘Boytox’, the ...nti-ageing jab ‘Breastox’ – or b...e;colletage, can reduce the appearance of wrinkles...easts, leaving smoother, younger-looking skin. , ...- Transform, the UK’s largest group of cosm...
(Date:11/6/2009)...UVER, Nov. 6 /PRNewswire-FirstCall/ - Cardiome Pha...ced that it will report financial results for the ...ing of Monday, November 9, 2009. Cardiome will hol...ern (6:00am Pacific) on that day to discuss the re...al 416-695-7806 or 888-789-9572 and reference conf...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 2Health News:Updegraff Vision Proudly Supports The Pediatric Cancer Foundation 3Health News:UK Boobs Get a Boost with 'Breastox' 2Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...SBURG, Pa., March 28 Governor Edward G.,Rendell t...hysicians, which,explains the March 31 deadline fo...re Provider:, In December, I wrote informing you ... of thousands of uninsured,Pennsylvanians., As yo...
...THE GOVERNMENT CURB AN OVERLY AGGRESSIVE VACCINATI... Mo., March 28 Parents of children who,regressed ...g cautious,optimism that government health officia...by reported details of a conference call held earl...
...LO, N.Y., March 28 Dr. Eaton E.,Lattman, currentl...anvyl,Krieger School of Arts and Sciences at Johns...f Executive Officer and Executive Director of the,... has degrees from Harvard and JHU and at JHU has s...
...ase in specific white blood cells could warn docto...March 28 (HealthDay News) -- Researchers at Temple...er that denotes the progression of the virus that ... (HIV), according to a study published in the Marc...
...er, patients stay on the new medications longer, s... News) -- Newer, so-called second-generation antip...ridol in treating a first episode of schizophrenia...study authors said. , "When we compared newer drug...
...w Special Video and Feedback on Web Site -, PHOEN...munized, TriWest Healthcare Alliance,s network doc...nd their families with peace of mind during the,go...ns its TRICARE beneficiaries in thanking and showi...
Other Medicine News:Health News:Governor Rendell Writes to Physicians to Explain MCare Fund Assessment Deadline 2Health News:MITOCHONDRIAL DYSFUNCTION, VACCINES AND AUTISM: 1 in 50 Children Could Be at Risk 2Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 2Health News:Hauptman-Woodward Appoints Dr. Eaton Lattman CEO and Executive Director 3Health News:Biomarker May Signal HIV Progression 2Health News:New Drugs No Better Than Older Ones for Schizophrenia 2Health News:New Drugs No Better Than Older Ones for Schizophrenia 3Health News:TriWest Recognizes Contributions of TRICARE Docs to Military Community on Doctors' Day 2
(Date:11/6/2009)...ire/ -- , - Trial Will Compare NXL103 Wit...f Multi-Resistant Staphylococcus Aureus (MRSA) Inf...tical company focused on the discovery and,develop... significant global,problem of microbial resistanc...ibacterial NXL103 (flopristin/linopristin), has st...
(Date:11/5/2009)... Transcept Pharmaceutica...cal company focused on the development and commerc...portant therapeutic needs in the field of neurosci...eleconference with management to discuss third qua...12, 2009, at 5:00 p.m. Eastern Standard Time. Fin...
(Date:11/5/2009)...ewswire/ -- Renee Cobos, MD, a board certified der...at the University of California, Irvine, announced...us results with Thermage CPT®. The updated sy...ntouring, features a new vibrating hand piece that... comfort. ,, "Thermage has always been popular...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Good news for some hard to treat hepatitis C patients 49004 1Good news for some hard to treat hepatitis C patients 49004 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 1MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 2MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 3MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE a Global Phase 2 3 Clinical Trial of Teplizumab in Type 1 Diabetes 4596 4A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 1A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 2A Power Energy Generation Systems Ltd Signs a Biomass Based DG Contract with Sanmenxia New Energy Bio Electricity Co Ltd 12639 3
...ril 9, 2008 /PRNewswire-FirstCall/ - Echo,Therapeu...sitive results,from its human feasibility study of...ration, needle-free, non-invasive skin permeation ...ransdermal continuous glucose monitoring,(tCGM) sy...ital critical,care markets. Prelude incorporates E...
...ion continuance needed to reduce cardiovascular,ri...o,receive microwave therapy for enlarged prostates...hat could raise their risk of a heart attack or,st... recently in Mayo,Clinic Proceedings., The Mayo C...ceived,transurethral microwave therapy at four med...
Other Medicine Technology:Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 2Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 3Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 4Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System 5Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges 2Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges 3
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
...dth of infectious disease ELISA products make us a...ls for faster integration into the busy laboratory...creased reliability and run-to-run consistency. Ou...detection assays for a wide range of serological a...
Medicine Products: